Detalles de la búsqueda
1.
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1671-1682, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29756171
2.
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1747, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29943159
3.
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.
Ann Hematol
; 94(12): 2033-42, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26420061
4.
Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment.
Med Mycol
; 46(3): 259-63, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17885950
Resultados
1 -
4
de 4
1
Próxima >
>>